CORC

浏览/检索结果: 共191条,第1-10条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
Water Availability Assessment of Shale Gas Production in the Weiyuan Play, China 期刊论文
SUSTAINABILITY, 2019, 卷号: 11, 期号: 3
作者:  Wu, Xia;  Xia, Jun;  Guan, Baoshan;  Yan, Xinming;  Zou, Lei
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/05
Quantitative proteomics reveals mitochondrial respiratory chain as a dominant target for carbon ion radiation: Delayed reactive oxygen species generation caused DNA damage 期刊论文
FREE RADICAL BIOLOGY AND MEDICINE, 2019, 卷号: 130
作者:  Fan, Peng-Cheng;  Zhang, Yao;  Wang, Yu;  Wei, Wei;  Zhou, Yan-Xia
收藏  |  浏览/下载:8/0  |  提交时间:2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载:35/0  |  提交时间:2019/12/05
Observation of e(+) e(-) -> eta Y(2175) at center-of-mass energies above 3.7 GeV 期刊论文
PHYSICAL REVIEW D, 2019, 卷号: 99, 期号: 1
作者:  Ablikim, M.;  Achasov, M. N.;  Ahmed, S.;  Ai, X. C.;  Albayrak, O.
收藏  |  浏览/下载:25/0  |  提交时间:2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:36/0  |  提交时间:2019/12/05
Water scarcity assessment based on estimated ultimate energy recovery and water footprint framework during shale gas production in the Changning play 期刊论文
JOURNAL OF CLEANER PRODUCTION, 2019, 卷号: 241
作者:  Wu, Xia;  Xia, Jun;  Guan, Baoshan;  Liu, Ping;  Ning, Like
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载:32/0  |  提交时间:2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:29/0  |  提交时间:2019/12/05
The extraction research on evaluation rules for students based on discernibility matrix 会议论文
作者:  Yan-Ying, Fan;  Zi-Min, Zhang;  Guan-Ping, Chen;  Shi-Yong, Zheng
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05
A consensus on immunotherapy from the 2017 Chinese Lung Cancer Summit expert panel 期刊论文
TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 卷号: 7, 期号: 3
作者:  Wu, Yi-Long;  Wang, Chang-Li;  Liao, Mei-Lin;  Guan, Zhong-Zhen;  Gao, Chen-Yan
收藏  |  浏览/下载:22/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace